<DOC>
	<DOCNO>NCT01270516</DOCNO>
	<brief_summary>The investigator determine administration HMB ( hydroxymethylbutyrate ) EPA ( eicosapentaenoic acid ) increase diaphragm limb muscle strength patient breathe machine intensive care unit . The investigator first measure strength diaphragm limb muscle ( quadriceps ) use magnetic stimulators activate muscle . Muscle size measure use ultrasound measure diaphragm thickness quadriceps thickness . The investigator also perform vastus lateralis muscle biopsy . Patients randomize receive either placebo ( saline 30 ml every 12 hour via GI tract , EPA ( 1000 mg give every 12 hour via GI tract ) , HMB ( 1500 mg give every 12 hour via GI tract ) , combination EPA ( 1000 mg give every 12 hour via GI tract ) HMB ( 1500 mg give every 12 hour via GI tract ) . Drugs give 10 day ; end time ( day 11 ) , strength measurement , ultrasound muscle size measurement , vastus lateralis biopsy repeat . On day 21 additional followup set diaphragm quadriceps strength size measurement make ( biopsy repeat last set measurement ) . Patients follow clinically patient outcome ( mortality , duration mechanical ventilation study entry ) record .</brief_summary>
	<brief_title>Effect EPA HMB Strength ICU Patients</brief_title>
	<detailed_description>Objectives . There single objective study , namely , determine early administration either EPA HMB prevent reverse development respiratory muscle weakness critically ill , mechanically ventilated patient . The investigator plan randomize patient accept protocol administration either control ( saline enteral control solution ) , EPA administration ( enteral EPA ) , HMB ( enteral HMB ) , combination EPA HMB . Drugs administer 10 day measurement diaphragm quadriceps strength size perform immediately ( day 0 ) immediately ( day 11 ) period drug administration . A third set measurement ( diaphragm quadriceps strength size ) perform day 21 . Vastus lateralis muscle biopsy also take day 0 11 ; biopsy perform day 21 assessment . The investigator also perform chart review ass ventilator mechanic ( respiratory system static compliance inspiratory airway resistance ) time initial strength assessment . Patient outcome ( time mechanical ventilation mortality ) also record . The investigator would expect mean diaphragm strength limb muscle strength measurement similar four group immediately initiation drug administration . The hypothesis support , post drug administration , diaphragm limb muscle strength high patient receive EPA and/or HMB control group receive active drug . Study Design . The basic study design : 1. measure magnetic stimulate Pdi twitch quadriceps strength size , obtain muscle biopsy vastus lateralis quadriceps , determine respiratory system compliance , determine airway resistance , perform chart review , 2. randomize patient treatment either : control solution ( 30 ml enteral saline solution every 12 hour ) , EPA ( 30 ml enteral solution contain 1000 mg EPA every 12 hour ) , HMB ( 30 ml enteral solution contain 1500 mg HMB every 12 hour ) EPA ( 30 ml enteral solution contain 1000 mg EPA every 12 hour ) HMB ( 30 ml enteral solution contain 1500 mg HMB every 12 hour ) . 3. continue drug 10 day 4. day 11 remeasure magnetic stimulate Pdi twitch quadriceps strength , repeat measurement diaphragm quadriceps size ( i.e . thickness ) , repeat vastus lateralis muscle biopsy , determine respiratory system compliance , determine airway resistance , perform chart review . 5. day 21 remeasure magnetic stimulate Pdi twitch quadriceps strength , repeat measurement diaphragm quadriceps size ( i.e . thickness ) , perform another chart review . For chart review investigator obtain follow information : age , sex , diagnosis , reason institution mechanical ventilation , vital sign , bedside parameter mechanical ventilation use ( include mode ventilation , duration ventilation , level oxygen , breath volume rate , % triggered breath ) , recent arterial blood gas value , chest radiograph reading , record assessment limb muscle strength mental status . Study Population . Adult patient require mechanical ventilation 24 hour one University Kentucky adult ICU 's asked participate . Patients exclude : ( ) physician care patient determines patient unstable tolerate measurement , ( b ) patient require high dose pressor ( 15 mcg/min norepinephrine 15 mg/kg/min dopamine ) , ( c ) patient require 80 % FiO2 15 cm H2O PEEP , ( ) patient cardiac pacemaker implant defibrillator , ( e ) patient receive neuromuscular block agent within 48 hour precede test know preexist muscular disease , ( f ) patient recent history variceal bleeding , ( g ) patient excessively sedate mentally obtund judge inability follow verbal command . The investigator also study pregnant female , prisoner , institutionalize decisionally impaired patient . The goal recruit 80 patient study 24 month period ( 5 patients/month , 20 patient per experimental group ) . The investigator study patient regardless sex , race , adult age . It hop sufficient minority woman study subject population representative general patient population , investigator somewhat constrain number available patient day day makeup patient population UK ICU 's . Inclusion minority woman make study result generally applicable .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<criteria>Adult patient require mechanical ventilation 24 hour one University Kentucky adult ICU 's The physician caring patient determines patient unstable tolerate measurement , If patient require high dose pressor ( 15 mcg/min norepinephrine 15 mg/kg/min dopamine ) , If patient require 80 % FiO2 15 cm H2O PEEP , If patient cardiac pacemaker implant defibrillator , If patient receive neuromuscular block agent within 48 hour precede test know preexist muscular disease , If patient recent history variceal bleeding , If patient excessively sedate mentally obtund judge inability follow verbal command . We study pregnant female , prisoner , institutionalize decisionally impaired patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>diaphragm</keyword>
	<keyword>limb muscle</keyword>
	<keyword>EPA</keyword>
	<keyword>HMB</keyword>
	<keyword>ICU patient</keyword>
</DOC>